Recent progress in antiretrovirals - lessons from resistance

被引:35
作者
Adamson, Catherine S. [1 ]
Freed, Eric O. [1 ]
机构
[1] NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, Frederick, MD 21702 USA
关键词
D O I
10.1016/j.drudis.2008.02.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent failures in efforts to develop an effective vaccine against HIV-1 infection have emphasized the importance of antiretroviral therapy in treating HIV-1-infected patients. Thus far, inhibitors of two viral enzymes, reverse transcriptase and protease, have had a profoundly positive impact on the survival of HIV-1-infected patients. However, new inhibitors that act at diverse steps in the viral replication cycle are urgently needed because of the development of resistance to currently available antiretrovirals. This review summarizes recent progress in antiretroviral drug discovery and development by specifically focusing on novel inhibitors of three phases of replication: viral entry, integration of the viral DNA into the host cell genome and virus particle maturation.
引用
收藏
页码:424 / 432
页数:9
相关论文
共 94 条
[91]   Inhibition of HIV-1 maturation via drug association with the viral Gag protein in immature HIV-1 particles [J].
Zhou, J ;
Huang, L ;
Hachey, DL ;
Chen, CH ;
Aiken, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (51) :42149-42155
[92]   Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation [J].
Zhou, J ;
Yuan, X ;
Dismuke, D ;
Forshey, BM ;
Lundquist, C ;
Lee, KH ;
Aiken, C ;
Chen, CH .
JOURNAL OF VIROLOGY, 2004, 78 (02) :922-929
[93]   Human immunodeficiency virus type I resistance to the small molecule maturation inhibitor 3-O-(3′,3′-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in gag [J].
Zhou, Jing ;
Chen, Chin Ho ;
Aiken, Christopher .
JOURNAL OF VIROLOGY, 2006, 80 (24) :12095-12101
[94]   The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3′, 3′-dimethylsuccinyl}-betulinic acid [J].
Zhou J. ;
Chen C.H. ;
Aiken C. .
Retrovirology, 1 (1)